Simplex Trading, LLC Exelixis, Inc. Transaction History

Simplex Trading, LLC

$2.81 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 02, 2024	BUY	$19.25 - $24.13 $1.01 Million - $1.27 Million	52,560 New	52,560 $1.26 Million
Q1 2023 Apr 27, 2023	BUY	$16.3 - $19.41 $127,009 - $151,242	7,792 New	7,792 $151,000
Q3 2022 Nov 04, 2022	SELL	$15.68 - $22.27 $1.09 Million - $1.55 Million	-69,598 Reduced 81.52%	15,775 $247,000
Q2 2022 Aug 03, 2022	SELL	$17.44 - $23.16 $263,064 - $349,345	-15,084 Reduced 15.02%	85,373 $1.78 Million
Q1 2022 May 02, 2022	BUY	$17.03 - $22.67 $1.16 Million - $1.54 Million	67,935 Added 208.89%	100,457 $2.28 Million
Q4 2021 Feb 23, 2022	BUY	$15.84 - $21.88 $97,922 - $135,262	6,182 Added 23.47%	32,522 $594,000
Q3 2021 Oct 28, 2021	SELL	$16.3 - $21.14 $19,560 - $25,368	-1,200 Reduced 4.36%	26,340 $490,000
Q2 2021 Aug 12, 2021	BUY	$17.95 - $25.56 $464,456 - $661,365	25,875 Added 1554.05%	27,540 $501,000
Q1 2021 Apr 26, 2021	SELL	$20.53 - $25.22 $561,187 - $689,388	-27,335 Reduced 94.26%	1,665 $0
Q4 2020 Feb 02, 2021	BUY	$18.39 - $24.8 $310,735 - $419,045	16,897 Added 139.61%	29,000 $582,000
Q3 2020 Oct 14, 2020	BUY	$20.67 - $26.94 $250,169 - $326,054	12,103 New	12,103 $295,000
Q2 2020 Jul 13, 2020	SELL	$16.46 - $27.42 $206,062 - $343,270	-12,519 Closed	0 $0
Q1 2020 Apr 29, 2020	SELL	$14.46 - $21.8 $375,020 - $565,383	-25,935 Reduced 67.44%	12,519 $215,000
Q4 2019 Feb 05, 2020	BUY	$15.15 - $18.89 $477,103 - $594,883	31,492 Added 452.34%	38,454 $677,000
Q3 2019 Oct 15, 2019	BUY	$17.68 - $22.65 $11,898 - $15,243	673 Added 10.7%	6,962 $123,000
Q2 2019 Jul 26, 2019	BUY	$18.93 - $24.75 $119,050 - $155,652	6,289 New	6,289 $134,000
Q4 2018 Jan 16, 2019	SELL	$13.65 - $21.8 $106,961 - $170,824	-7,836 Closed	0 $0
Q3 2018 Oct 23, 2018	BUY	$15.87 - $22.4 $118,009 - $166,566	7,436 Added 1859.0%	7,836 $138,000
Q2 2018 Jul 30, 2018	BUY	$18.56 - $22.45 $7,423 - $8,980	400 New	400 $8,000
Q1 2018 Apr 26, 2018	SELL	$22.15 - $31.89 $17,121 - $24,650	-773 Closed	0 $0
Q4 2017 Jan 10, 2018	SELL	$24.23 - $30.93 $622,807 - $795,024	-25,704 Reduced 97.08%	773 $23,000
Q3 2017 Oct 25, 2017	BUY	$23.35 - $29.24 $618,237 - $774,187	26,477	26,477 $641,000

Others Institutions Holding EXEL

# of Institutions

503

Shares Held

244M

Call Options Held

2.54M

Put Options Held

2.29M

Black Rock Inc. New York, NY

33.5M
Shares

$1.2 Billion
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

29.3M
Shares

$1.05 Billion
0.01% of portfolio
Farallon Capital Management LLC San Francisco, CA

25.4M
Shares

$913 Million
3.31% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

15.4M
Shares

$552 Million
0.63% of portfolio
State Street Corp Boston, MA

11.4M
Shares

$411 Million
0.01% of portfolio

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.6B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account